TipRanks
Evercore Partners Inc (MX:EVR)
:EVR
Mexico Market
EarningsQ2 2026 Earnings Report

Evercore Partners (EVR) Q2 2026 Earnings Report

0 Followers

MX:EVR Q2 2026 EPS Results

Actual EPS$49.88
Consensus EPS$51.92
Beat/MissMissed by -$2.04
One Year Ago EPS$41.48

MX:EVR Q2 2026 Revenue Results

Actual Revenue$17.11B
Expected Revenue$16.88B
Beat/MissBeat by +$232.14M
YoY Revenue Growth+19.15%

Earnings Announcement Details

QuarterQ2 2026
Date07/29/2026
TimeBefore Open
Conference CallWednesday, July 29, 2026
MX:EVR Upcoming Earnings
Evercore Partners's next earnings date is estimated for October 28, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

MX:EVR Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 29, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a strongly positive performance driven by record revenues, significant YoY growth in earnings and operating income, broad-based strength across advisory, underwriting, ECM, equities and wealth management, and continued capital returns and talent investment. The principal concerns were elevated non-compensation expenses (some due to intentional investments and episodic items), modest margin pressure versus some historical ranges, and industry softness in the middle-market/sponsor segments. Management framed the expense increases as targeted investments to support continued growth and expects many of the episodic items to ease in future quarters.
Company Guidance
Management stopped short of formal revenue guidance but said activity and backlog are near record levels and they expect continued strength in the second half and into next year; Q2 adjusted net revenues were $1.0 billion (+19% YoY) and adjusted diluted EPS $2.91 (+20%), with first-half revenues $2.4 billion (+56%) and first-half adjusted EPS $10.48 (+77%). Q2 adjusted operating income was $190 million (H1 $544 million, +21% and +99%), adjusted operating margins were 19% (Q2) and 22.7% (H1), and GAAP net revenues, operating income and EPS were $990 million, $147 million and $2.32. By product, Q2 advisory fees were ~$776 million (+11%), underwriting $97 million (+201%), commissions $64 million (+9%), asset management/admin ~$25 million (+15%) and other revenue ~$39 million; Q2 adjusted comp ratio was 63.5% (down ~190 bps YoY), adjusted non-comp expense was $175 million (17.5% non-comp ratio, H1 non-comp ratio 13.5% v. last year 14.2%), adjusted tax rate 29.4%. Balance sheet and capital return metrics: cash and investment securities ~ $2.4 billion, returned $150 million in Q2 (≈330,000 shares repurchased + dividends), $823 million returned YTD (including $734 million repurchases at ~$325/share), and adjusted diluted shares 43.7 million (down >730,000 Q/Q).
Record Quarterly and First-Half Revenue
Adjusted net revenues of $1.0 billion for Q2 2026, up 19% year-over-year; record first-half adjusted revenues of $2.4 billion, up 56% year-over-year.
Strong Earnings Performance
Adjusted diluted EPS of $2.91 in Q2 2026, up 20% year-over-year; adjusted EPS of $10.48 for the first half, up 77% year-over-year. GAAP EPS for Q2 was $2.32.
Operating Income and Margins Expanded
Adjusted operating income of $190 million in Q2 (up 21% YoY) and $544 million for the first half (up 99% YoY). Adjusted operating margins were 19% in Q2 and 22.7% for the first half.
Advisory and Underwriting Strength
Adjusted advisory fees of approximately $776 million in Q2, up 11% YoY. Underwriting fees of $97 million in Q2, the best quarter ever and up 201% YoY; underwriting revenues up 76% for the first half.
Record Performance in Multiple Businesses
Record Q2 revenues in North America Strategic Advisory, Private Funds Group, equities, Underwriting and Wealth Management; Wealth Management quarter-end AUM of $16.2 billion.
Equity Capital Markets and Equities Momentum
ECM had its best quarter ever, acted as book runner on 19 transactions including Parabilis Medicine $771 million IPO (largest biotech IPO ever) and Red Cat $259 million follow-on; equities business delivered record Q2 revenues.
Private Funds and Private Capital Advisory Resilience
Private Funds Group delivered a record Q2 despite a subdued fundraising market; Private Capital Advisory remained market-leading and active, contributing to non-M&A businesses generating >40% of total revenues over the last 12 months.
Strong Balance Sheet and Capital Returns
Cash and investment securities near $2.4 billion as of June 30; returned $150 million of capital in Q2 (approx. 330,000 shares repurchased + dividends) and $823 million YTD, including $734 million of repurchases at an average price of ~$325/share; adjusted diluted share count down to 43.7 million.
Talent Investment and Global Expansion
19 new Senior Managing Directors added YTD (11 external hires, 8 promotions), total SMDs now 188 with over 50 ramping; new hires across strategic areas and additional European presence including Frankfurt and Stockholm, and successful integration of Robey Warshaw.

MX:EVR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Oct 28, 2026
2026 (Q3)
59.77 / -
59.645
2026 (Q2)
51.92 / 49.88
41.47720.25% (+8.40)
2026 (Q1)
93.02 / 129.06
59.817115.76% (+69.24)
2025 (Q4)
69.36 / 87.93
58.44550.44% (+29.48)
2025 (Q3)
55.69 / 59.65
34.96470.59% (+24.68)
2025 (Q2)
30.46 / 41.48
31.02233.70% (+10.46)
2025 (Q1)
26.33 / 59.82
36.50763.85% (+23.31)
2024 (Q4)
48.40 / 58.45
34.62268.81% (+23.82)
2024 (Q3)
34.21 / 34.96
22.28156.92% (+12.68)
2024 (Q2)
27.89 / 31.02
16.45488.54% (+14.57)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed